Page last updated: 2024-09-05

sorafenib and folic acid

sorafenib has been researched along with folic acid in 8 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(folic acid)
Trials
(folic acid)
Recent Studies (post-2010) (folic acid)
6,5207305,25130,0011,94510,195

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Gong, F; Ma, J; Shen, J; Zhang, F; Zhang, L; Zhang, P1
Dong, M; Kong, FM; Li, YJ; Zhou, JP1
Choi, HG; Choi, JY; Kim, JO; Poudel, BK; Thapa, RK; Yong, CS1
Cheng, Q; Gao, X; Guo, M; Jiang, P; Jiang, S; Liu, L; Liu, Q; Yao, H; Zhang, Q; Zheng, J1
Dave, V; Gupta, C; Sharma, R; Sur, S1

Reviews

1 review(s) available for sorafenib and folic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for sorafenib and folic acid

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index

2014
Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro.
    International journal of nanomedicine, 2013, Volume: 8

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Drug Carriers; Drug Delivery Systems; Ferrocyanides; Folic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Micelles; Microscopy, Electron, Transmission; Niacinamide; Phenylurea Compounds; Sorafenib

2013
Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
    International journal of pharmaceutics, 2015, Jul-15, Volume: 489, Issue:1-2

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Folic Acid; Humans; Iron; Liver Neoplasms; Magnetic Phenomena; Nanoparticles; Niacinamide; Phenylurea Compounds; Polyesters; Polyethylene Glycols; Sorafenib

2015
Receptor-targeted, drug-loaded, functionalized graphene oxides for chemotherapy and photothermal therapy.
    International journal of nanomedicine, 2016, Volume: 11

    Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Death; Drug Carriers; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Graphite; Hemolysis; Humans; Hyperthermia, Induced; KB Cells; Male; Nanomedicine; Niacinamide; Phenylurea Compounds; Phototherapy; Rats; Sorafenib; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

2016
Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma.
    Journal of experimental & clinical cancer research : CR, 2019, Aug-19, Volume: 38, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; beta-Cyclodextrins; Carcinoma, Renal Cell; Cell Cycle; Cell Movement; Cell Proliferation; Drug Synergism; Female; Folic Acid; Hepatocyte Growth Factor; Humans; Kidney Neoplasms; Kringles; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Polyethylene Glycols; Polyethyleneimine; Sorafenib; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019
Folic acid modified gold nanoparticle for targeted delivery of Sorafenib tosylate towards the treatment of diabetic retinopathy.
    Colloids and surfaces. B, Biointerfaces, 2020, Volume: 194

    Topics: Diabetes Mellitus; Diabetic Retinopathy; Drug Delivery Systems; Folic Acid; Gold; Humans; Metal Nanoparticles; Sorafenib

2020